Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

(StatePoint) Like many bladder cancer survivors, Karen S. often reflects on her personal experience with the disease, and the support she received throughout her healthcare journey. Karen was ...

A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...

Data from patients treated in the late 1990s is now emerging, making it possible to assess the effect of improved detection and subsequent changes in patient management on recurrence rates ( Table 2).

A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...

Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...

Role of circulating tumor DNA (ctDNA) in locally advanced (LA) and metastatic urothelial cancer (mUC). Clinical features of patients with malignant lesions detected by BLC only (A) and those with risk ...

Photocure ASA ((PHCUF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...

Add Yahoo as a preferred source to see more of our stories on Google. Research shows a urine test looking for genetic markers of bladder cancer can more than halve the number of cystoscopies needed to ...

When using a diagnostic tool, it is common see to more false-positives as the number of true-positives increases ( Table 1). The accuracy of fluorescence cystoscopy is also affected by previous ...